. . . . "We categorized conditions such as acid reflux, esophageal irritation, nausea, vomiting, and heartburn as ???mild upper gastrointestinal (GI) events.??? Pooled analyses of 18 trials of etidronate showed greater odds for treated participants than for placebo participants." . .